Compare ZURA & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZURA | ADV |
|---|---|---|
| Founded | 2022 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 293.0M |
| IPO Year | N/A | N/A |
| Metric | ZURA | ADV |
|---|---|---|
| Price | $6.36 | $0.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $11.38 | $2.00 |
| AVG Volume (30 Days) | ★ 872.7K | 658.9K |
| Earning Date | 11-13-2025 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,502,796,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.97 | $0.76 |
| 52 Week High | $6.63 | $2.84 |
| Indicator | ZURA | ADV |
|---|---|---|
| Relative Strength Index (RSI) | 63.92 | 53.54 |
| Support Level | $5.46 | $0.76 |
| Resistance Level | $6.62 | $1.18 |
| Average True Range (ATR) | 0.64 | 0.09 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 88.09 | 54.40 |
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.